GALECTIN THERAPEUTICS INC — Director's Dealing 2013

Nov 18, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-11-15

Reporting Person: CZIRR JAMES C (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-15	Common Stock	P	1000	$6.897	Acquired	844450	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9457422	Indirect
Common Stock	179232	Indirect

Footnotes

F1: Reporting Person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Czirr disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.